NCT01795144View on ClinicalTrials.gov

Incretin Regulation of Insulin Secretion in Monogenic Diabetes

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Monogenic Diabetes
Interventions
DRUG

GLP-1

OGTT IGI IGI with GLP-1 infusion OGTT with Exendin 9-39 infusion

DRUG

Exendin 9-39

OGTT IGI IGI with GLP-1 infusion OGTT with Exendin 9-39 infusion

Trial Locations (1)

60637

University of Chicago, Chicago

All Listed Sponsors
lead

University of Chicago

OTHER

NCT01795144 - Incretin Regulation of Insulin Secretion in Monogenic Diabetes | Biotech Hunter | Biotech Hunter